share_log

【港股通】宜明昂科跌8.08% 折让约16.27%配售合共3315万股

金吾资讯 ·  Nov 21, 2024 01:35

金吾财讯 | 宜明昂科(01541)折价配股,盘初股价应声下行,截至发稿,跌8.08%,报7.74港元,成交额700.59万港元。

消息面上,公司于今日交易时段前与配售代理订立配售协议,据此,公司拟配售合共3315万股新H股,占扩大后已发行股本约8.14%。每股配售价为7.05港元,较上交易日收市价折让约16.27%。

配售事项集资总额约2.34亿港元,净额约2.30亿港元,拟将净额约30%将用于为在中国进行IMM2510联合化疗一线治疗非小细胞肺癌(NSCLC)和三阴性乳腺癌(TNBC)以及治疗其他实体瘤的Ib/II期及进一步临床研究提供资金;约30%将用于为在中国进行IMM2510联合IMM27M治疗晚期实体瘤的Ib期及进一步临床研究提供资金;约10%将用于为在中国进行IMM01(替达派西普)与阿扎胞苷联合疗法以及IMM01(替达派西普)与替雷利珠单抗联合疗法的关键性临床研究提供资金;及约30%将用于补充本公司营运资金,并作一般企业用途。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 316

Recommended

Write a comment

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.